Jump to content

Transcriptome instability

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Jafield (talk | contribs) at 10:43, 9 January 2018. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Transcriptome instability is a genome-wide, pre-mRNA splicing-related characteristic of certain cancers. In general, pre-mRNA splicing is dysregulated in a high proportion of cancerous cells.[1]Skotheim, R I; Nees, M (2007). "Alternative splicing in cancer: noise, functional, or systematic?". The International Journal of Biochemistry & Cell Biology. 39 (7–8): 1432–49. doi:10.1016/j.biocel.2007.02.016. PMID 17416541.</ref>[2][3] Interestingly, for certain types of cancer, like in colorectal and prostate, the number of splicing errors per cancer has been shown to vary greatly between individual cancers, a phenomenon referred to as transcriptome instability.[4][5] Transcriptome instability has further been shown to correlate grealty with reduced expression level of splicing factor genes. Interestingly, mutation of [[DNMT3A]] has been demonstrated to contribute to hematologic malignancies, and that [[DNMT3A]]-mutated cell lines exhibit transcriptome instability as compared to their isogenic wildtype counterparts [6].

  1. ^ Cite error: The named reference Skotheim and Nees 2007 was invoked but never defined (see the help page).
  2. ^ Bauer, Joseph Alan; He, Chunjiang; Zhou, Fang; Zuo, Zhixiang; Cheng, Hanhua; Zhou, Rongjia (2009). Bauer, Joseph Alan (ed.). "A Global View of Cancer-Specific Transcript Variants by Subtractive Transcriptome-Wide Analysis". PLoS ONE. 4 (3): e4732. doi:10.1371/journal.pone.0004732. PMC 2648985. PMID 19266097.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  3. ^ Cite error: The named reference Sveen 2015 was invoked but never defined (see the help page).
  4. ^ Sveen, A; Ågesen, TH; Nesbakken, A; Rognum, TO; Lothe, RA; Skotheim, RI (2011). "Transcriptome instability in colorectal cancer identified by exon microarray analyses: Associations with splicing factor expression levels and patient survival". Genome Medicine. 15: 672. doi:10.1186/1471-2164-15-672. PMC 3219073. PMID 25109687.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  5. ^ Sveen, A; Johannessen, B; Teixeira, MR; Lothe, RA; Skotheim, RI (2014). "Transcriptome instability as a molecular pan-cancer characteristic of carcinomas". BMC Genomics. 3: 32. doi:10.1186/gm248. PMC 4137096. PMID 21619627.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  6. ^ Banaszak, LG; Giudice, V; Zhao, X; Wu, Z; Gao, S; Hosokawa, K; Keyvanfar, K; Townsley, DM; Gutierrez-Rodrigues, F; Ibanez, MdPF; Kajigaya, S; Young, NS (2018). "Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing". Blood Cells, Molecules, and Diseases.